- “Rosana Barbosa, mother of little 4-year-old Olivia, shared her story with Purodiol with us. Her daughter completed a year without seizures. Play and check your testimonial.”
- The subtitles are not 100% accurate, but close enough to understand the gist of what she is saying.
- In 2017/18, Isodiolex, Purodiol, and Isoderm received approval from Brazilian Health Regulatory Agency (Anvisa) for the treatment of Epilepsy and Parkinson’s disease. In addition, these products have been placed on the Special Category List for alternative therapies which will enable it to be prescribed by doctors and neurologists. For more information about ANVISA, here is their website.
All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. Candlr is not receiving payment or commissions from companies for shared content on Candlr website unless its specified. View full disclaimer HERE.